4
Changes in Ownership
BioXcel Therapeutics, Inc. Filed Acc 0001104659-24-073000
O'Neill Vincent sold 155 shares at $1.29 ($199)
- O'Neill Vincent acquired 521 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-06-14 | Exercise or conversion : show line 1 in the form 10b5-1 | +521 | 3,679 | D | ||
| 2024-06-17 | Sale : show line 2 in the form 10b5-1 | −155 | $1.29 | $199 | 3,524 | D |
| Open-market sales · 155 sh · avg $1.29 · $199 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-06-14 | Exercise or conversion : show line 3 in the form 10b5-1 Restricted Stock Units | −521 | 3,648 | D |
Loading xslF345X05/tm2417544-2_4seq1.xml…